MadhavThambisettyMDPhD

PubMed

• 4 citations
  Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation.
  Bruno Dubois, Nicolas Villain, Lon Schneider, Nick Fox, Noll Campbell
  JAMA Neurology. 2024-12-01
• Sex differences in the trajectories of plasma biomarkers, brain atrophy, and cognitive decline relative to amyloid onset.
  Cassandra M Joynes, Murat Bilgel, Yang An, Abhay R Moghekar, Nicholas J Ashton
  Alzheimer's & Dementia. 2024-11-28
• Proteomic analysis of APOEε4 carriers implicates lipid metabolism, complement and lymphocyte signaling in cognitive resilience.
  Keenan A Walker, Yang An, Abhay Moghekar, Ruin Moaddel, Michael R Duggan
  Molecular Neurodegeneration. 2024-10-31

Journal Articles

• Evidence of altered phosphatidylcholine metabolism in Alzheimer's disease.  
  Whiley L, Sen A, Heaton J et al., NEUROBIOLOGY OF AGING 35(2):271-8, 2014
• Pharmacologic inhibition of ROCK2 suppresses amyloid-ß production in an Alzheimer disease mouse model  
  Herskowitz JH, Feng, Higginbotham L et al., J NEUROSCIENCE 33(49):19086-98, 2013
• Abnormal gephyrin immunoreactivity associated with Alzheimer disease pathologic changes.  
  Hales CM, Rees H, Seyfried NT et al., J NEUROPATHOL EXP NEUROL 72(11):1009-15, 2013
• Alzheimer disease risk genes and the age-at-onset phenotype.  
  Thambisetty M et al., NEUROBIOLOGY OF AGING 34(11) 2696.e1-5, 2013
• Impaired Glucose Tolerance in Midlife and Longitudinal Changes in Brain Function During Aging.  
  Thambisetty M et al., NEUROBIOLOGY OF AGING 34(10):2271-6, 2013
• Glucose intolerance, insulin resistance and Alzheimer’s disease pathology in the Baltimore Longitudinal Study of Aging.  
  Thambisetty M et al., JAMA NEUROLOGY 70(9): 1167-72, 2013
• Alzheimer risk variant clusterin (CLU) and brain function in aging.  
  Thambisetty M et al., BIOLOGICAL PSYCHIATRY 73(5):399-405, 2013
• The effect of complement CR1 on brain amyloid burden during aging and its modification by APOE genotype  
  Thambisetty M et al., BIOLOGICAL PSYCHIATRY 73(5):422-8, 2013
• Processing and memory for emotional and neutral material in amyotrophic lateral sclerosis  
  Cuddy M, Papps BJ, Thambisetty M, et al., Amyotrophic Lateral Sclerosis. 13(6):592-8, 2012
• Plasma based markers of [11C] PiB-PET brain amyloid burden  
  Kiddle S, Thambisetty M et al., PLoS ONE 7(9):e44260, 2012
• Plasma biomarkers associated with ApoE genotype and Alzheimer's disease.  
  Soares H, Potter W, Pickering E et al., ARCHIVES OF NEUROLOGY 69(10):1310-7, 2012
• Baseline cardiovascular risk predicts subsequent changes in resting brain function.  
  Beason-Held L, Thambisetty M, Deib G et al., STROKE 43(6):1542- 1547, 2012
• The utility of 11C-arachidonate PET to study in vivo dopaminergic neurotransmission in humans.  
  Thambisetty M et al., JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM 32(4):676-84,, 2012
• Join now to see all

Abstracts/Posters

• The Effect of CR1 on Brain Amyloid Burden during Aging and its Modification by APOE Genotype
  Thambisetty M, An Yang, Nalls M et al, 6th Human Amyloid Imaging meeting, Miami, FL, 1/1/2012
• Impaired glucose tolerance predicts longitudinal changes in brain function during aging in non- demented elderly
  Thambisetty M, Beason-Held L, An Y et al, 15th International Conference on Alzheimer’s Disease and Related Disorders, Vancouver, Canada, 1/1/2012
• Alzheimer’s risk variant clusterin (CLU) and brain function in aging
  Thambisetty M, Beason-Held L, Kraut M et al, 14th International Conference on Alzheimer’s Disease and Related Disorders, Paris, 1/1/2011
• Combinatorial, multimodal biomarkers from large variable datasets: findings from the Addneuromed study
  Lovestone S, Thambisetty M, Kronenberg D, et al, International Journal of Neuropsychopharmacology, 1/1/2010
• Clusterin Is a Plasma Biomarker of Severity, Progression and Pathology in Alzheimer's Disease
  Thambisetty M, Resnick SM, Ferrucci L, et al, 12th International Conference on Alzheimer’s Disease and Related Disorders, Vienna, 1/1/2009
• Proteomic Identification of Plasma Biomarkers for Hippocampal Atrophy in Alzheimer’s Disease
  Thambisetty M, Kinsey A, Hye A, et al, 11th International Conference on Alzheimer’s Disease and Related Disorders, Chicago, IL, 1/1/2008
• The Utility of 11C- Arachidonate PET to Study Human Dopaminergic Neurotransmission
  Thambisetty M, Liow J-S, Herscovitch P, et al, Society for Neuroscience, 1/1/2008
• Emotional memory and depression in ALS
  Cuddy M, Papps B, Thambisetty M, et al, Journal of Neurology, Neurosurgery and Psychiatry, 1/1/2007
• A Combined Proteomic and Neuroimaging Approach to Identifying Biomarkers in Alzheimer's Disease
  Madhav Thambisetty, Abdul Hye, Catherine Foy, et al, World Congress of Neurology, Sydney, Australia, 11/1/2005
• A novel 2-step diagnostic approach for RLS disease classification
  Rye DB, Bliwise D, Iranzo A, et al, 18th Annual Meeting of the Associated Professional Sleep Societies, 6/6/2004
• Involvement of lipoprotein receptor LR11 in Alzheimer’s disease and amyloid clearance
  Lah JJ, Offe K, Scherzer CR, et al, Soc. Neurosci. Abst, 1/1/2003
• Ataxic optic neuropathy
  Madhav TR, Scherzer CR, Yu Z, et al, Frank Walsh Society, North American Neuro-ophthalmology Society, 1/1/2001
• Antidepressant treatment and gene expression of brain derived neurotrophic factor (BDNF)
  Zetterstrom TS, Madhav TR, Coppell AL, et al, European Journal of Neuroscience, 1/1/2000
• Effect of 5-HT depletion on the dendritic spine density of granule cells in the adult rat hippocampus
  Madhav TR, Grahame-Smith DG, Zetterstrom TS, et al, Soc. Neurosci. Abst, 1/1/2000
• Evidence for the co-distribution of Trkb mRNA with serotonergic cell bodies in the rat raphe nucleus
  Zetterstrom TS, Madhav TR, Pei, Q, Fundamental and Clinical Phaemacology, 1/1/1999
• Manipulation of brain 5-HT levels affects gene expression for BDNF in rat brain
  Zetterstrom TS, Pei Q, Madhav TR, Grahame-Smith DG, British Journal of Pharmacology, 1/1/1998
• An in vivo model of serotoninergic axonal sprouting in the adult rat brain
  Madhav TR, Moorman JM, Leslie RA, Grahame-Smith DG, International School of Brain Research, 1/1/1997
• Join now to see all

Lectures

• APOE and partners in the post GWAS era: discovering biomarkers and understanding mechanisms in Alzheimer’s Disease 
  6/1/2013
• Is it memory loss or Alzheimer’s disease? Know the facts 
  5/1/2012
• Neuroimaging and Genetic Findings in Alzheimer’s Disease from the Baltimore Longitudinal Study of Aging 
  11/1/2011
• Clinical features, Diagnosis and Management of Alzheimer’s disease 
  1/1/2011
• Alzheimer’s disease: New Frontiers in Biomarkers and Therapeutics 
  11/1/2009
• Novel Approaches to Peripheral Biomarker Discovery in Alzheimer’s disease 
  11/1/2009
• Proteomic and Neuroimaging Approaches to Peripheral Biomarkers in Alzheimer’s disease 
  1/1/2007
• Novel Approaches to Peripheral Biomarkers in Alzheimer’s Disease 
  8/1/2006
• A Novel Approach to Peripheral Biomarkers in Alzheimer's Disease 
  Department of Biochemistry, National University of Singapore - 3/1/2006
• Genetic Testing and Counselling in Dementia 
  Athens, Greece - 9/1/2005
• Proteomic Approaches to Early Diagnosis of Alzheimer’s Disease 
  India - 5/1/2005
• Join now to see all